Wednesday, March 24, 2021 6:24:42 PM
BY MT Newswires
— 10:19 PM ET 03/11/2021
10:19 PM EST, 03/11/2021 (MT Newswires) -- Two insiders -- Christopher M Foskett, Officer, and Devin McGranahan, Officer -- today, sold 18,000 shares of Fiserv (FISV) having a market value of approximately $2,213,160, as disclosed in form 4 documents filed with the SEC. There have been 4 insiders with buy/sell transactions in the past 90 days prior to these filings. These trades have resulted in the purchase of 9,100 company shares and the sale of 40,258,479 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 40,267,379 shares and have averaged 6,714,263 shares per transaction over this time period.
Today's Insider Activity
Insider buy/sell trading at Fiserv (FISV) is higher than the 27 peer company average over the last 90-day period. The Transaction & Payment Services peer group saw 40 buy/sell trades during this period for an average of 1.5 transactions per company. The number of shares per buy/sell trade for Fiserv (FISV) insiders was also higher. Within the peer group there were 3,404,282 shares purchased and 40,498,483 shares sold with company insiders disposing of 927,355 shares on average
Recent FISV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2024 08:11:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2024 08:10:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/24/2024 11:19:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2024 11:14:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2024 08:52:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2024 06:46:16 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/03/2024 08:34:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2024 08:33:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2024 08:31:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:29:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:27:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:26:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2024 08:25:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/27/2024 08:25:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2024 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/21/2024 08:40:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/20/2024 08:23:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2024 08:17:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/15/2024 08:00:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 08:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 08:49:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 08:47:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM